RNfinity
Research Infinity Logo, Orange eye of horus, white eye of Ra
  • Home
  • Submit
    Research Articles
    Ebooks
  • Articles
    Academic
    Ebooks
  • Info
    Home
    Subject
    Submit
    About
    News
    Submission Guide
    Contact Us
  • Login/sign up
    Login
    Register

Biomedical

Pregnancy and Risk of Intracerebral Hemorrhage

rnfinity

info@rnfinity.com

orcid logo

Kazuyoshi Aoyama,

Kazuyoshi Aoyama

Department of Anesthesia and Pain Medicine, The Hospital for Sick Children, Toronto, Ontario, Canada


Joel G. Ray

Joel G. Ray

Department of Medicine, University of Toronto, Ontario, Canada


  Peer Reviewed

copyright icon

© attribution CC-BY

  • 0

rating
408 Views

Added on

2024-10-22

Doi: http://dx.doi.org/10.1001/jamanetworkopen.2020.2844

Related Subjects
Anatomy
Biochemistry
Epidemiology
Genetics
Neuroscience
Psychology
Oncology
Medicine
Musculoskeletal science
Pediatrics
Pathology
Pharmacology
Physiology
Psychiatry
Primary care
Women and reproductive health

Abstract

The study highlights pregnancy's role in increasing the risk of intracerebral hemorrhage (ICH), especially within the first 12 weeks postpartum. Key risk factors include chronic hypertension, gestational hypertension, and preeclampsia. Treatment strategies focus on blood pressure control, the use of low-dose aspirin for high-risk women, and managing coagulation issues. Timely diagnosis and neuroimaging are critical for managing ICH, with neuroconsultation recommended in severe cases.

Key Questions and Answers

1. What are the key risk factors for intracerebral hemorrhage (ICH) during pregnancy?

Risk factors include chronic hypertension, gestational hypertension, preeclampsia, and eclampsia. The postpartum period, particularly within 12 weeks, carries the highest risk.

2. How does preeclampsia contribute to ICH risk?

Preeclampsia and eclampsia significantly increase the likelihood of ICH. Women with these conditions face a 9.23 times higher risk of developing ICH.

3. What are the key treatments for preventing ICH during pregnancy?

Treatment involves managing hypertension with antihypertensive medications, initiating low-dose aspirin in high-risk women, and correcting maternal coagulation abnormalities in conditions like preeclampsia.

Summary Video Not Available

Review 0

Login

ARTICLE USAGE


Article usage: Oct-2024 to May-2025
Show by month Manuscript Video Summary
2025 May 44 44
2025 April 63 63
2025 March 59 59
2025 February 47 47
2025 January 72 72
2024 December 57 57
2024 November 48 48
2024 October 18 18
Total 408 408
Show by month Manuscript Video Summary
2025 May 44 44
2025 April 63 63
2025 March 59 59
2025 February 47 47
2025 January 72 72
2024 December 57 57
2024 November 48 48
2024 October 18 18
Total 408 408
Related Subjects
Anatomy
Biochemistry
Epidemiology
Genetics
Neuroscience
Psychology
Oncology
Medicine
Musculoskeletal science
Pediatrics
Pathology
Pharmacology
Physiology
Psychiatry
Primary care
Women and reproductive health
copyright icon

© attribution CC-BY

  • 0

rating
408 Views

Added on

2024-10-22

Doi: http://dx.doi.org/10.1001/jamanetworkopen.2020.2844

Related Subjects
Anatomy
Biochemistry
Epidemiology
Genetics
Neuroscience
Psychology
Oncology
Medicine
Musculoskeletal science
Pediatrics
Pathology
Pharmacology
Physiology
Psychiatry
Primary care
Women and reproductive health

Follow Us

  • Xicon
  • Contact Us
  • Privacy Policy
  • Terms and Conditions

5 Braemore Court, London EN4 0AE, Telephone +442082758777

© Copyright 2025 All Rights Reserved.